Nvidia & Chip Stocks Falling, Novavax Vaccine, Zscaler Upgrade
Novavax Stock Is Up Again on Speculation Over the Fate of Its Covid Shot -- Barrons.com
These Stocks Are Moving the Most Today: Tesla, Nvidia, Domino's, Spirit AeroSystems, IBM, Novavax, and More -- Barrons.com
Confusion Surrounds FDA's Delay in Granting Novavax Vaccine Approval, STAT Says
Novavax Believes COVID BLA 'Approvable' Upon Alignment on Details With FDA
'Regulatory Headwinds Set to Bite,' Says Top Analyst on Novavax Stock (NVAX)
Latest Update on U.S. FDA BLA for Novavax's COVID-19 Vaccine
Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus
Benzinga Bulls And Bears: Netflix, Novavax, Intel — And The Market Begins To Bounce Back
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
News Highlights: Top Company News of the Day - Friday at 5 PM ET
Novavax Inc. Stock Slides 5.7%, Underperforms Competitors
Market Chatter: Novavax Asked by FDA to Run Additional Trial on COVID-19 Vaccine
Novavax Slips After WSJ Report on FDA Request for Another Vaccine Study
Express News | Moderna Shares Lose Ground With Volume Spick in Late Afternoon, Last Down 2%; Pfizer Shares Lose Some Steam, Last up 0.6%
Express News | Novavax Shares Sink Sharply to Session Low in Volume Spike, Last Down 8.6% at $6.45; WSJ Reports That FDA Asked for New Trial for Delayed Covid-19 Shot
FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot -- WSJ
Novavax (NasdaqGS:NVAX) Announces Positive SHIELD-Utah Study Results
Shareholders May Not Overlook Novavax Insiders Selling US$713k In Stock
Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?